A Cambridge-headquartered company developing technology for breast cancer surgery is set to be acqui...
Locate Bio has raised £9.2 million to fund a clinical study of LDGraft, a bone graft substitute for...
Owlstone Medical has secured £5.2 million to explore a path by which breath-based testing could be ...
A company which provides handheld devices that help people self-manage insomnia has received over £...
‘Organ-on-a-chip’ firm CN Bio has raised almost £17 million in the first close of its Series B ...
BenevolentAI is to slash more jobs and close its US office amid a boardroom coup led by founder Ken ...
Qureight has raised almost £7 million in Series A funding to accelerate drug development in lung an...
The founder of BenevolentAI is leading a boardroom coup at the high-profile MedTech. Ken Mulvany ...
e-therapeutics plc plans to de-list from the London Stock Exchange’s junior AIM market after slamm...
Presymptom Health has raised £1.5 million in follow-on seed and grant funding that will help accele...
The CTO of BenevolentAI is to leave the MedTech company. Dr Daniel Neil (pictured) joined the com...
Neupulse has secured £2.5 million funding to commercialise the world’s first wearable device to t...